This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dcthttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n12http://clinicaltrials.gov/ct2/show/
n8http://www.upi.com/HealthBusiness/
n17https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n21http://news.bbc.co.uk/1/hi/health/
n9http://www.opexatherapeutics.com/
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Tcelna
rdf:type
yago:PhysicalEntity100001930 yago:Antigen115037339 yago:Matter100020827 yago:Substance100020090 yago:Vaccine104517535 yago:WikicatVaccines yago:Immunogen103562739 dbo:Drug
rdfs:label
Tcelna
rdfs:comment
Tcelna (formerly known as Tovaxin) is an anti-T cell vaccine being studied in multiple sclerosis (MS). As of 2016 it is in phase II trials.
dct:subject
dbc:Vaccines
dbo:wikiPageID
4341065
dbo:wikiPageRevisionID
932500387
dbo:wikiPageWikiLink
dbr:U.S._Food_and_Drug_Administration dbr:Double_blind dbc:Vaccines dbr:Multiple_sclerosis dbr:Vaccine dbr:Placebo dbr:T_cell
dbo:wikiPageExternalLink
n8:view.php%3FStoryID=20060309-042811-3384r n9:%3Fpage=tovaxin&section=tovaxin n12:NCT01684761%3Fterm=NCT01684761&rank=1 n21:4787430.stm
owl:sameAs
n17:4vWnV freebase:m.0by0_9 yago-res:Tcelna wikidata:Q7690604
dbp:wikiPageUsesTemplate
dbt:Primary_sources dbt:Citation_needed dbt:Multiple_issues dbt:News_release dbt:Refimprove dbt:Reflist
dbo:abstract
Tcelna (formerly known as Tovaxin) is an anti-T cell vaccine being studied in multiple sclerosis (MS). As of 2016 it is in phase II trials.
gold:hypernym
dbr:Vaccine
prov:wasDerivedFrom
wikipedia-en:Tcelna?oldid=932500387&ns=0
dbo:wikiPageLength
2837
foaf:isPrimaryTopicOf
wikipedia-en:Tcelna